aciclovir "paranova" 400 mg tabletter
paranova danmark a/s - aciclovir - tabletter - 400 mg
valganciclovir "medical valley" 450 mg filmovertrukne tabletter
medical valley invest ab - valganciclovirhydrochlorid - filmovertrukne tabletter - 450 mg
clavuzop 500 mg+125 mg filmovertrukne tabletter
nordic prime aps - amoxicillintrihydrat, kaliumclavulanat - filmovertrukne tabletter - 500 mg+125 mg
amoxicillin/clavulansyre "orifarm" 500 mg + 125 mg filmovertrukne tabletter
orifarm a/s - amoxicillintrihydrat, kaliumclavulanat - filmovertrukne tabletter - 500 mg + 125 mg
aciclovir "nordic prime" 800 mg tabletter
nordic prime aps - aciclovir - tabletter - 800 mg
aciclovir "nordic prime" 200 mg tabletter
nordic prime aps - aciclovir - tabletter - 200 mg
caspofungin "viatris" 50 mg pulver til koncentrat til infusionsvæske, opløsning
viatris limited - caspofunginacetat - pulver til koncentrat til infusionsvæske, opløsning - 50 mg
caspofungin "viatris" 70 mg pulver til koncentrat til infusionsvæske, opløsning
viatris limited - caspofunginacetat - pulver til koncentrat til infusionsvæske, opløsning - 70 mg
fornega 50 mg pulver til koncentrat til infusionsvæske, opløsning
pharmathen s.a. - caspofunginacetat - pulver til koncentrat til infusionsvæske, opløsning - 50 mg
cancidas (previously caspofungin msd)
merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika til systemisk brug - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.